An Evaluation of CXCR4 Targeting with PAMAM Dendrimer Conjugates for Oncologic Applications
The chemokine receptor 4 (CXCR4) is a promising diagnostic and therapeutic target for the management of various cancers. CXCR4 has been utilized in immunotherapy, targeted drug delivery, and endoradiotherapy. Poly(amidoamine) [PAMAM] dendrimers are well-defined polymers with unique properties that h...
Saved in:
Main Authors: | Wojciech G. Lesniak (Author), Babak Behnam Azad (Author), Samit Chatterjee (Author), Ala Lisok (Author), Martin G. Pomper (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Twenty Years of Research on Cyclodextrin Conjugates with PAMAM Dendrimers
by: Hidetoshi Arima
Published: (2021) -
Effect of methotrexate conjugated PAMAM dendrimers on the viability of MES-SA uterine cancer cells
by: Samreen Khatri, et al.
Published: (2014) -
Doxorubicin-Conjugated PAMAM Dendrimers for pH-Responsive Drug Release and Folic Acid-Targeted Cancer Therapy
by: Mengen Zhang, et al.
Published: (2018) -
Curcumin encapsulation using dendrimer PAMAM G4 conjugated with polyethylene glycol to improve the properties of gel dossage form
by: Rahmah Elfiyani, et al.
Published: (2018) -
Toxicity of Hexyl Acrylate Modified PAMAM Dendrimer
by: Mohammad Ashkan Naderian, et al.
Published: (2018)